iSpecimen Inc.
Close on Oct 19, 2026
- Market cap
- $1.27M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | Before market open | $2.86M | $-0.19 | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | Before market open | $2.29M | $-0.32 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 14, 2024 | Before market open | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Oct 23, 2023 | Before market open | – | – | – |
| Q2 FY2023 Ended Jun 30, 2023 | Aug 2, 2023 | Before market open | – | – | – |
| Q1 FY2023 Ended Mar 31, 2023 | May 4, 2023 | Before market open | $2.95M | $-0.27 | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 14, 2023 | Before market open | – | – | – |
| Q3 FY2022 Ended Sep 30, 2022 | Nov 8, 2022 | Before market open | – | – | – |
| Q2 FY2022 Ended Jun 30, 2022 | Aug 4, 2022 | Before market open | – | – | – |
| Q1 FY2022 Ended Mar 31, 2022 | May 10, 2022 | Before market open | – | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Feb 17, 2022 | During market hours | – | – | – |
| Q2 FY2021 Ended Jun 30, 2021 | Aug 10, 2021 | Before market open | – | – | – |
Press releases
Announcements iSpecimen filed with the SEC
PRESS RELEASE DATED AUGUST 6, 2026, ANNOUNCING THE PRICING OF THE OFFERING
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED AUGUST 7, 2026, ANNOUNCING THE CLOSING OF THE OFFERING
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE DATED MAY 8, 2026
Material agreement · Listing notice · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED APRIL 24, 2026
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED APRIL 9, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED FEBRUARY 6, 2026 (MILESTONE 2 ANNOUNCEMENT)
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED FEBRUARY 6, 2026 (OPERATIONAL ACHIEVEMENTS ANNOUNCEMENT)
Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE DATED SEPTEMBER 4, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED AUGUST 21, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED AUGUST 7, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 31, 2025, ANNOUNCING THE PRICING OF THE PRIVATE PLACEMENT (FURNISHED HEREWITH)
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED AUGUST 4, 2025, ANNOUNCING THE CLOSING OF THE PRIVATE PLACEMENT (FURNISHED HEREWITH)
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE DATED JULY 24, 2025, ANNOUNCING THE PRICING OF THE OFFERING
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 25, 2025, ANNOUNCING THE CLOSING OF THE OFFERING
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE DATED JANUARY 16, 2025
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED DECEMBER 20, 2024
Executive or director change · Other events · EX-99.1 to Form 8-K
iSpecimen Reports Positive Results on Next Day Quote Program for
Other events · EX-99.1 to Form 8-K
Appoints Robert Lim as CEO and Director
Executive or director change · Other events · EX-99.1 to Form 8-K
iSpecimen Inc. Announces Pricing of $5 Million
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
iSpecimen Inc. Announces Closing of $5 Million
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
Mass., September 11, 2024 – iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”),
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
iSpecimen Reports Second Quarter 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
August 2024 Investor Presentation Nasdaq: ISPC The Online Marketplace for Human Biospecimens Transforming Biospecimen Procurement
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
iSpecimen Reports First Quarter 2024 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
The Online Marketplace for Human
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
March 14 2024 – iSpecimen Inc . (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
The Online Marketplace for Human
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Third Quarter 2023 Financial and Operating Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
November 2023 Investor Presentation Nasdaq: ISPC The Online Marketplace for Human Biospecimens Transforming Biospecimen Procurement
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
iSpecimen Preannounces Third Quarter 2023 Revenue
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Organizational Changes to Enhance Operational Efficiencies and Drive Profitability
Regulation FD disclosure · EX-99.1 to Form 8-K
iSpecimen Reports Second Quarter 2023 Financial
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
August 2023 Investor Presentation Nasdaq: ISPC The Online Marketplace for Human Biospecimens Transforming Biospecimen Procurement
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
LEXINGTON, MA, May 4, 2023 – iSpecimen Inc. (Nasdaq:
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
An online marketplace for human biospecimens
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K